Psychopharmacology, An Issue of Child and Adolescent Psychiatric Clinics of North America
Psychopharmacology is a dominant treatment in child and adolescent psychiatry with proven benefits to young patients. The authors present topics related to PSYCHOPHARMACOLOGY ISSUES: Ethical issues, Treatment planning, Side effects, Neural correlates, and Pharmacogenomics. They address DRUGS FOR SPECIFIC DISEASES: Anxiety, Depression, Eating disorders, Sleep disorders, Psychosis and Schizophrenia, High-risk for bilpolar and schizophrenia, Bipolar, ADHD, and Autism. Each topic presents an Overview of the Disease or Issue, Empirical evidence for ethical issues, Treatment summaries that include dose ranges, side effects, contraindications, and how the drugs are used specifically for a disorder. Treatment in the presence of co-morbid conditions, Long-term evidence, and Conclusions and Future directions complete the presentations. Clinical vignettes are provided that exemplify the main points of the topic.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
Acad Child Adolesc acute ADHD adolescents with bipolar adults adverse effects agents antidepressant anxiety disorders Arch Gen Psychiatry aripiprazole assessment associated atomoxetine attention-deficit/hyperactivity disorder atypical antipsychotics behavior bipolar disorder brain Child Adolesc Psychiatry Child Adolesc Psychopharmacol Child and Adolescent children and adolescents children with ASD citalopram Clin Psychiatry clinical clinicians clozapine cognitive comorbid diagnosis divalproex dosage dose double-blind drug DVPX eating disorders efficacy fluoxetine gene improvement increased initial insomnia interventions JAm Acad Child lamotrigine lithium major depressive mania manic medication melatonin meta-analysis metabolic methylphenidate mg/d monotherapy mood stabilizers nervosa obesity olanzapine onset open-label outcome paroxetine patients pediatric bipolar disorder Pharmacogenomics pharmacologic pharmacotherapy placebo placebo-controlled trial potential Psychiatry psychosis psychotic psychotropic quetiapine randomized controlled trials reported risk risperidone schizophrenia sertraline side effects significant sleep SSRIs stimulant suicide symptoms syndrome therapy topiramate treat treatment venlafaxine weight gain youth Ziprasidone